User menu

The influence of ageing on the development and management of rheumatoid arthritis

Bibliographic reference Boots, Annemieke M H ; Maier, Andrea B ; Stinissen, Piet ; Masson, Pierre ; Lories, Rik J ; et. al. The influence of ageing on the development and management of rheumatoid arthritis. In: Nature Reviews Rheumatology, Vol. 9, no.10, p. 604-613 (2013)
Permanent URL
  1. Konrat Cécile, Boutron Isabelle, Trinquart Ludovic, Auleley Guy-Robert, Ricordeau Philippe, Ravaud Philippe, Underrepresentation of Elderly People in Randomised Controlled Trials. The Example of Trials of 4 Widely Prescribed Drugs, 10.1371/journal.pone.0033559
  2. Macieira-Coelho Alvaro, Cell division and aging of the organism, 10.1007/s10522-011-9346-3
  3. Sperka Tobias, Wang Jianwei, Rudolph K. Lenhard, DNA damage checkpoints in stem cells, ageing and cancer, 10.1038/nrm3420
  4. Kirkwood T. B. L., Evolution of ageing, 10.1038/270301a0
  5. KIRKWOOD THOMAS B. L., KAPAHI PANKAJ, SHANLEY DARYL P., Evolution, stress, and longevity, 10.1046/j.1469-7580.2000.19740587.x
  6. Ljubuncic Predrag, Reznick Abraham Z., The Evolutionary Theories of Aging Revisited – A Mini-Review, 10.1159/000200772
  7. Fulop T., Larbi A., Witkowski J. M., McElhaney J., Loeb M., Mitnitski A., Pawelec G., Aging, frailty and age-related diseases, 10.1007/s10522-010-9287-2
  8. Lang Pierre-Olivier, Michel Jean-Pierre, Zekry Dina, Frailty Syndrome: A Transitional State in a Dynamic Process, 10.1159/000211949
  9. Fried L. P., Tangen C. M., Walston J., Newman A. B., Hirsch C., Gottdiener J., Seeman T., Tracy R., Kop W. J., Burke G., McBurnie M. A., Frailty in Older Adults: Evidence for a Phenotype, 10.1093/gerona/56.3.m146
  10. Bandeen-Roche K., Xue Q.-L., Ferrucci L., Walston J., Guralnik J. M., Chaves P., Zeger S. L., Fried L. P., Phenotype of Frailty: Characterization in the Women's Health and Aging Studies, 10.1093/gerona/61.3.262
  11. Garonzik-Wang Jacqueline M., Frailty and Delayed Graft Function in Kidney Transplant Recipients, 10.1001/archsurg.2011.1229
  12. Makary Martin A., Segev Dorry L., Pronovost Peter J., Syin Dora, Bandeen-Roche Karen, Patel Purvi, Takenaga Ryan, Devgan Lara, Holzmueller Christine G., Tian Jing, Fried Linda P., Frailty as a Predictor of Surgical Outcomes in Older Patients, 10.1016/j.jamcollsurg.2010.01.028
  13. Yao Xu, Hamilton Robert G., Weng Nan-ping, Xue Qian-Li, Bream Jay H., Li Huifen, Tian Jing, Yeh Shu-Hui, Resnick Barbara, Xu Xiyan, Walston Jeremy, Fried Linda P., Leng Sean X., Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults, 10.1016/j.vaccine.2011.04.077
  14. Abadir P. M., Foster D. B., Crow M., Cooke C. A., Rucker J. J., Jain A., Smith B. J., Burks T. N., Cohn R. D., Fedarko N. S., Carey R. M., O'Rourke B., Walston J. D., Identification and characterization of a functional mitochondrial angiotensin system, 10.1073/pnas.1101507108
  15. Leng Sean X., Cappola Anne R., Andersen Ross E., Blackman Marc R., Koenig Kathleen, Blair Michael, Walston Jeremy D., Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty, 10.1007/bf03324545
  16. Varadhan R., Walston J., Cappola A. R., Carlson M. C., Wand G. S., Fried L. P., Higher Levels and Blunted Diurnal Variation of Cortisol in Frail Older Women, 10.1093/gerona/63.2.190
  17. Gameiro Catia, Changes in the immune system during menopause and aging, 10.2741/e190
  18. Gomez Christian R, Boehmer Eric D, Kovacs Elizabeth J, The aging innate immune system, 10.1016/j.coi.2005.07.013
  19. Krabbe Karen Suárez, Pedersen Maria, Bruunsgaard Helle, Inflammatory mediators in the elderly, 10.1016/j.exger.2004.01.009
  20. Panda Alexander, Arjona Alvaro, Sapey Elizabeth, Bai Fengwei, Fikrig Erol, Montgomery Ruth R., Lord Janet M., Shaw Albert C., Human innate immunosenescence: causes and consequences for immunity in old age, 10.1016/
  21. Shaw Albert C, Joshi Samit, Greenwood Hannah, Panda Alexander, Lord Janet M, Aging of the innate immune system, 10.1016/j.coi.2010.05.003
  22. Goronzy Jorg J., Shao Lan, Weyand Cornelia M., Immune Aging and Rheumatoid Arthritis, 10.1016/j.rdc.2010.03.001
  23. Lindstrom Tamsin M., Robinson William H., Rheumatoid Arthritis: A Role for Immunosenescence? : LINK BETWEEN RHEUMATOID ARTHRITIS AND AGING, 10.1111/j.1532-5415.2010.02965.x
  24. Scullion Jane, Tuberculosis and older people : By reading this article and writing a practice profile, you can gain ten continuing education points (CEPs). You have up to a year to send in your practice profile and guidelines on how to write and submit a profile are featured immediately after the continuing professional development article., 10.7748/nop2003.
  25. Frasca Daniela, Blomberg Bonnie B., Aging Affects Human B Cell Responses, 10.1007/s10875-010-9501-7
  26. Lee N., Shin M. S., Kang I., T-Cell Biology in Aging, With a Focus on Lung Disease, 10.1093/gerona/glr237
  27. Hakim Frances T., Memon Sarfraz A., Cepeda Rosemarie, Jones Elizabeth C., Chow Catherine K., Kasten-Sportes Claude, Odom Jeanne, Vance Barbara A., Christensen Barbara L., Mackall Crystal L., Gress Ronald E., Age-dependent incidence, time course, and consequences of thymic renewal in adults, 10.1172/jci200522492
  28. Geginat J., Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines, 10.1182/blood-2002-11-3577
  29. Broux Bieke, Markovic-Plese Silva, Stinissen Piet, Hellings Niels, Pathogenic features of CD4+CD28– T cells in immune disorders, 10.1016/j.molmed.2012.06.003
  30. Weng Nan-ping, Akbar Arne N., Goronzy Jorg, CD28− T cells: their role in the age-associated decline of immune function, 10.1016/
  31. Vallejo Abbe N., Bryl Ewa, Klarskov Klaus, Naylor Stephen, Weyand Cornelia M., Goronzy Jörg J., Molecular Basis for the Loss of CD28 Expression in Senescent T Cells, 10.1074/jbc.m207352200
  32. Valenzuela H, Divergent Telomerase and CD28 Expression Patterns in Human CD4 and CD8 T Cells Following Repeated Encounters with the Same Antigenic Stimulus, 10.1006/clim.2002.5271
  33. KOCH S., LARBI A., OZCELIK D., SOLANA R., GOUTTEFANGEAS C., ATTIG S., WIKBY A., STRINDHALL J., FRANCESCHI C., PAWELEC G., Cytomegalovirus Infection: A Driving Force in Human T Cell Immunosenescence, 10.1196/annals.1396.043
  34. van Leeuwen E. M. M., Remmerswaal E. B. M., Vossen M. T. M., Rowshani A. T., Wertheim-van Dillen P. M. E., van Lier R. A. W., ten Berge I. J. M., Emergence of a CD4+CD28- Granzyme B+, Cytomegalovirus-Specific T Cell Subset after Recovery of Primary Cytomegalovirus Infection, 10.4049/jimmunol.173.3.1834
  35. Schirmer M., J. Immunol., 161, 1018 (1998)
  36. Vallejo A. N., Schirmer M., Weyand C. M., Goronzy J. J., Clonality and Longevity of CD4+CD28null T Cells Are Associated with Defects in Apoptotic Pathways, 10.4049/jimmunol.165.11.6301
  37. Vallejo Abbe N., Mueller Robert G., Hamel David L., Way Amanda, Dvergsten Jeffrey A., Griffin Patricia, Newman Anne B., Expansions of NK-like αβT cells with chronologic aging: Novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells, 10.1016/j.arr.2010.09.006
  38. Heyn H., Li N., Ferreira H. J., Moran S., Pisano D. G., Gomez A., Diez J., Sanchez-Mut J. V., Setien F., Carmona F. J., Puca A. A., Sayols S., Pujana M. A., Serra-Musach J., Iglesias-Platas I., Formiga F., Fernandez A. F., Fraga M. F., Heath S. C., Valencia A., Gut I. G., Wang J., Esteller M., Distinct DNA methylomes of newborns and centenarians, 10.1073/pnas.1120658109
  39. Liu Ying, Chen Yingxuan, Richardson Bruce, Decreased DNA methyltransferase levels contribute to abnormal gene expression in “senescent” CD4+CD28− T cells, 10.1016/j.clim.2009.03.529
  40. Schmidt D., Mol. Med., 2, 608 (1996)
  41. Schmidt D, Goronzy J J, Weyand C M, CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity., 10.1172/jci118638
  42. Kremer Joel M., Westhovens Rene, Leon Marc, Di Giorgio Eduardo, Alten Rieke, Steinfeld Serge, Russell Anthony, Dougados Maxime, Emery Paul, Nuamah Isaac F., Williams G. Rhys, Becker Jean-Claude, Hagerty David T., Moreland Larry W., Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig, 10.1056/nejmoa035075
  43. Arai Yasumichi, Takayama Michiyo, Abe Yukiko, Hirose Nobuyoshi, Adipokines and Aging, 10.5551/jat.7039
  44. Conde J., Discov. Med., 15, 73 (2013)
  45. Gómez Rodolfo, Conde Javier, Scotece Morena, Gómez-Reino Juan Jesus, Lago Francisca, Gualillo Oreste, What's new in our understanding of the role of adipokines in rheumatic diseases?, 10.1038/nrrheum.2011.107
  46. Olama Shereen M., Senna Mohammed K., Elarman Mohammed, Synovial/Serum leptin ratio in rheumatoid arthritis: the association with activity and erosion, 10.1007/s00296-010-1698-5
  47. Matarese Giuseppe, Procaccini Claudio, De Rosa Veronica, Horvath Tamas L., La Cava Antonio, Regulatory T cells in obesity: the leptin connection, 10.1016/j.molmed.2010.04.002
  48. Giles Jon T., Allison Matthew, Bingham Clifton O., Scott William M., Bathon Joan M., Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis, 10.1002/art.24789
  49. Matthews S. James, Lancaster Jason W., Urinary Tract Infections in the Elderly Population, 10.1016/j.amjopharm.2011.07.002
  50. Meyer Keith, The Role of Immunity and Inflammation in Lung Senescence and Susceptibility to Infection in the Elderly, 10.1055/s-0030-1265897
  51. Mori Toru, Leung Chi Chiu, Tuberculosis in the Global Aging Population, 10.1016/j.idc.2010.04.011
  52. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V, Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review, 10.1016/s0140-6736(05)67339-4
  53. Kumar Rajesh, Burns Edith A, Age-related decline in immunity: implications for vaccine responsiveness, 10.1586/14760584.7.4.467
  54. Lang Pierre-Olivier, Govind Sheila, Mitchell Wayne A., Siegrist Claire-Anne, Aspinall Richard, Vaccine effectiveness in older individuals: What has been learned from the influenza-vaccine experience, 10.1016/j.arr.2010.09.005
  55. Lang Pierre-Olivier, Mendes, Socquet, Assir, Govind, Aspinall, Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence, 10.2147/cia.s25215
  56. McElhaney Janet E., Influenza vaccine responses in older adults, 10.1016/j.arr.2010.10.008
  57. Fujihashi Kohtaro, Kiyono Hiroshi, Mucosal immunosenescence: new developments and vaccines to control infectious diseases, 10.1016/
  58. Giuliano Sandy, Ohanna Mickaël, Ballotti Robert, Bertolotto Corine, Advances in melanoma senescence and potential clinical application : Senescence in melanoma cells, 10.1111/j.1755-148x.2010.00820.x
  59. Lasithiotakis K. G., Melanoma Res., 20, 163 (2010)
  60. Finkel Toren, Serrano Manuel, Blasco Maria A., The common biology of cancer and ageing, 10.1038/nature05985
  61. de Vlam K., Clin. Exp. Rheumatol., 11, 393 (1993)
  62. Borchers Andrea T., Gershwin M. Eric, Giant cell arteritis: A review of classification, pathophysiology, geoepidemiology and treatment, 10.1016/j.autrev.2012.01.003
  63. Crowson Cynthia S., Matteson Eric L., Myasoedova Elena, Michet Clement J., Ernste Floranne C., Warrington Kenneth J., Davis John M., Hunder Gene G., Therneau Terry M., Gabriel Sherine E., The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases, 10.1002/art.30155
  64. Fujii H., Shao L., Colmegna I., Goronzy J. J., Weyand C. M., Telomerase insufficiency in rheumatoid arthritis, 10.1073/pnas.0811332106
  65. Weyand Cornelia M., Fujii Hiroshi, Shao Lan, Goronzy Jörg J., Rejuvenating the immune system in rheumatoid arthritis, 10.1038/nrrheum.2009.180
  66. Koetz K., Bryl E., Spickschen K., O'Fallon W. M., Goronzy J. J., Weyand C. M., T cell homeostasis in patients with rheumatoid arthritis, 10.1073/pnas.97.16.9203
  67. Goronzy Jörg J., Weyand Cornelia M., Immune aging and autoimmunity, 10.1007/s00018-012-0970-0
  68. Colmegna Inés, Diaz-Borjon Alejandro, Fujii Hiroshi, Schaefer Linda, Goronzy Jörg J., Weyand Cornelia M., Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis, 10.1002/art.23287
  69. Shao Lan, Fujii Hiroshi, Colmegna Inés, Oishi Hisashi, Goronzy Jörg J., Weyand Cornelia M., Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis, 10.1084/jem.20082251
  70. Kohler S., Thiel A., Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets, 10.1182/blood-2008-02-139154
  71. Lee W.-W., Yang Z.-Z., Li G., Weyand C. M., Goronzy J. J., Unchecked CD70 Expression on T Cells Lowers Threshold for T Cell Activation in Rheumatoid Arthritis, 10.4049/jimmunol.179.4.2609
  72. Singh K., Colmegna I., He X., Weyand C. M., Goronzy J. J., Synoviocyte Stimulation by the LFA-1-Intercellular Adhesion Molecule-2-Ezrin-Akt Pathway in Rheumatoid Arthritis, 10.4049/jimmunol.180.3.1971
  73. Mavragani Clio P., Moutsopoulos Haralampos M., Rheumatoid arthritis in the elderly, 10.1016/s0531-5565(98)00072-2
  74. Tutuncu Zuhre, Kavanaugh Arthur, Rheumatic Disease in the Elderly: Rheumatoid Arthritis, 10.1016/j.cger.2005.02.009
  75. van Schaardenburg Dirkjan, Breedveld Ferdinand C., Elderly-onset rheumatoid arthritis, 10.1016/0049-0172(94)90087-6
  76. Villa-Blanco Juan Ignacio, Calvo-Alén Jaime, Elderly Onset Rheumatoid Arthritis : Differential Diagnosis and Choice of First-Line and Subsequent Therapy, 10.2165/11316740-000000000-00000
  77. Kermani Tanaz A, Warrington Kenneth J, Polymyalgia rheumatica, 10.1016/s0140-6736(12)60680-1
  78. Chen Der-Yuan, Hsieh Tsu-Yi, Chen Yi-Ming, Hsieh Chia-Wie, Lan Joung-Liang, Lin Fang-Ju, Proinflammatory Cytokine Profiles of Patients with Elderly-Onset Rheumatoid Arthritis: A Comparison with Younger-Onset Disease, 10.1159/000164393
  79. Glennas A., J. Rheumatol., 27, 101 (2000)
  80. van der Heijde D. M., J. Rheumatol., 18, 1285 (1991)
  81. Gabriel Sherine E, Michaud Kaleb, Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases, 10.1186/ar2669
  82. Maradit-Kremers Hilal, Crowson Cynthia S., Nicola Paulo J., Ballman Karla V., Roger V�ronique L., Jacobsen Steve J., Gabriel Sherine E., Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study, 10.1002/art.20853
  83. Maradit-Kremers Hilal, Nicola Paulo J., Crowson Cynthia S., Ballman Karla V., Gabriel Sherine E., Cardiovascular death in rheumatoid arthritis: A population-based study, 10.1002/art.20878
  84. Nicola Paulo J., Maradit-Kremers Hilal, Roger V�ronique L., Jacobsen Steven J., Crowson Cynthia S., Ballman Karla V., Gabriel Sherine E., The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years, 10.1002/art.20855
  85. Madjid M., Willerson J. T., Inflammatory markers in coronary heart disease, 10.1093/bmb/ldr043
  86. Liao K. P., Solomon D. H., Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis, 10.1093/rheumatology/kes243
  87. Smitten Allison L, Simon Teresa A, Hochberg M C, Suissa Samy, A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis, 10.1186/ar2404
  88. Baecklund Eva, Iliadou Anastasia, Askling Johan, Ekbom Anders, Backlin Carin, Granath Fredrik, Catrina Anca Irinel, Rosenquist Richard, Feltelius Nils, Sundström Christer, Klareskog Lars, Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis, 10.1002/art.21675
  89. Niccoli Teresa, Partridge Linda, Ageing as a Risk Factor for Disease, 10.1016/j.cub.2012.07.024
  90. Askling Johan, Bongartz Tim, Malignancy and biologic therapy in rheumatoid arthritis : , 10.1097/bor.0b013e3282f7c706
  91. Doran Michele F., Crowson Cynthia S., Pond Gregory R., O'Fallon W. Michael, Gabriel Sherine E., Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study, 10.1002/art.10524
  92. De Keyser Filip, Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective, 10.2174/157339711794474620
  93. Salliot C, Dougados M, Gossec L, Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials, 10.1136/ard.2007.083188
  94. Crowson Cynthia S., Hoganson Deana D., Fitz-Gibbon Patrick D., Matteson Eric L., Development and validation of a risk score for serious infection in patients with rheumatoid arthritis, 10.1002/art.34530
  95. Seitz Cornelia S., Berens Nikolaus, Bröcker Eva-B., Trautmann Axel, Leg Ulceration in Rheumatoid Arthritis – An Underreported Multicausal Complication with Considerable Morbidity: Analysis of Thirty-Six Patients and Review of the Literature, 10.1159/000284583
  96. Summers G. D., Deighton C. M., Rennie M. J., Booth A. H., Rheumatoid cachexia: a clinical perspective, 10.1093/rheumatology/ken146
  97. Munro R, Capell H, Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response, 10.1136/ard.56.5.326
  98. Chen Y.-M., Chen L.-K., Lan J.-L., Chen D.-Y., Geriatric syndromes in elderly patients with rheumatoid arthritis, 10.1093/rheumatology/kep195
  99. Ziade N., J. Rheumatol., 35, 1950 (2008)
  100. Fraenkel L., Rabidou N., Dhar R., Are rheumatologists' treatment decisions influenced by patients' age?, 10.1093/rheumatology/kel144
  101. Schmajuk Gabriela, Schneeweiss Sebastian, Katz Jeffrey N., Weinblatt Michael E., Setoguchi Soko, Avorn Jerry, Levin Raisa, Solomon Daniel H., Treatment of older adult patients diagnosed with rheumatoid arthritis: Improved but not optimal, 10.1002/art.22890
  102. Radovits B. J., Fransen J., Eijsbouts A., van Riel P. L. C. M., Laan R. F. J. M., Missed opportunities in the treatment of elderly patients with rheumatoid arthritis, 10.1093/rheumatology/kep129
  103. Radovits B J, Kievit W, Fransen J, van de Laar M A F J, Jansen T L, van Riel P L C M, Laan R F J M, Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis, 10.1136/ard.2008.094730
  104. Bathon J. M., J. Rheumatol., 33, 234 (2006)
  105. Fleischmann R. M., J. Rheumatol., 30, 691 (2003)
  106. Lurati A., Biologics, 4, 1 (2010)
  107. Genevay Stéphane, Finckh Axel, Ciurea Adrian, Chamot Anne-Marie, Kyburz Diego, Gabay Cem, , Tolerance and effectiveness of anti–tumor necrosis factor α therapies in elderly patients with rheumatoid arthritis: A population-based cohort study, 10.1002/art.22688
  108. Galloway J. B., Hyrich K. L., Mercer L. K., Dixon W. G., Fu B., Ustianowski A. P., Watson K. D., Lunt M., Symmons D. P. M., , , Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly, 10.1093/rheumatology/keq242
  109. Schneeweiss Sebastian, Setoguchi Soko, Weinblatt Michael E., Katz Jeffrey N., Avorn Jerry, Sax Paul E., Levin Raisa, Solomon Daniel H., Anti–tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis, 10.1002/art.22600
  110. Dotan E., J. Natl Compr. Canc. Netw., 10, 213 (2012)
  111. Pallis A.G., Scarci M., Are we treating enough elderly patients with early stage non-small cell lung cancer?, 10.1016/j.lungcan.2011.05.025